Robert Weisskoff

Robert Weisskoff is a Senior Partner at F-Prime Capital based in Cambridge, Massachusetts, where he focuses on life sciences, therapeutics, AI medtech, and immuno-oncology. Before joining the venture capital firm in 2004, he served as an Associate Professor of Radiology at Harvard Medical School and Associate Director of the MGH-NMR Center at Massachusetts General Hospital. He holds a PhD in Physics from MIT, an MBA from Columbia University, and a physics degree from Harvard University, having authored over 100 scientific papers and secured six US patents. As an active investor bridging basic research and medical technology development, he currently holds board seats at companies including Adela, Affinia Therapeutics, and RareCyte. His career spanning 30 years in academia and the bioscience industry includes senior pharmaceutical roles and previous public board exits with Surface Oncology and Caribou Biosciences.